×
About 14,975 results

ALLMedicine™ Radical Prostatectomy Center

Research & Reviews  5,258 results

Alternatives to whole gland treatment for localized prostate cancer: a review of novel ...
https://doi.org/10.1097/MOU.0000000000000981
Current Opinion in Urology; Benjamin TGR, Williams TR et. al.

May 14th, 2022 - The mainstays of the management of clinically localized prostate cancer have historically rested upon active surveillance, radiation therapy, or radical prostatectomy. Although both radiation and surgical treatment of localized prostate cancer can...

Retzius-sparing versus modified anatomical structures preserving and retzius repairing ...
https://doi.org/10.1089/end.2022.0073
Journal of Endourology; Turkolmez K, Akpınar Ç et. al.

May 14th, 2022 - Objectives; To compare the short-term and 1-yr follow-up functional outcomes of modified anatomical structures preserving and retzius-repairing robot-assisted radical prostatectomy (APR-RARP) compared with retzius-sparing (RS) RARP. Methods; 80 co...

Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT03860987

May 13th, 2022 - Background: Most men diagnosed with prostate cancer will present with intermediate or high-risk disease, and many develop castrate resistant prostate cancer (CRPC) as curative strategies are often unsuccessful Treatment options typically involve r...

Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
https://clinicaltrials.gov/ct2/show/NCT02319837

May 13th, 2022 - The purpose of this study is to assess enzalutamide plus leuprolide in patients with high-risk nonmetastatic prostate cancer progressing after radical prostatectomy or radiotherapy or both.

see more →

Guidelines  8 results

Prostate Bed Delineation Guidelines for Postoperative Radiation Therapy: On Behalf Of T...
https://doi.org/10.1016/j.ijrobp.2020.11.010
International Journal of Radiation Oncology, Biology, Phy... Robin S, Jolicoeur M et. al.

Nov 14th, 2020 - Prostate bed (PB) irradiation is considered the standard postoperative treatment after radical prostatectomy (RP) for tumors with high-risk features or persistent prostate-specific antigen, or for salvage treatment in case of biological relapse. F...

The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of ...
https://doi.org/10.5858/arpa.2020-0015-RA
Archives of Pathology & Laboratory Medicine; Epstein JI, Amin MB et. al.

Jun 27th, 2020 - Controversies and uncertainty persist in prostate cancer grading. To update grading recommendations. Critical review of the literature along with pathology and clinician surveys. Percent Gleason pattern 4 (%GP4) is as follows: (1) report %GP4 in n...

ACR Appropriateness Criteria® Post-treatment Follow-up Prostate Cancer.
https://doi.org/10.1016/j.jacr.2018.03.019
Journal of the American College of Radiology : JACR; , Froemming AT et. al.

May 5th, 2018 - Diagnosis and management of prostate cancer post treatment is a large and complex problem, and care of these patients requires multidisciplinary involvement of imaging, medical, and surgical specialties. Imaging capabilities for evaluation of men ...

Brachytherapy for Patients With Prostate Cancer: American Society of Clinical Oncology/...
https://doi.org/10.1200/JCO.2016.72.0466
Journal of Clinical Oncology : Official Journal of the Am... Chin J, Rumble RB et. al.

Mar 28th, 2017 - Purpose To jointly update the Cancer Care Ontario guideline on brachytherapy for patients with prostate cancer to account for new evidence. Methods An Update Panel conducted a targeted systematic literature review and identified more recent random...

Sexual Rehabilitation After Treatment For Prostate Cancer-Part 2: Recommendations From ...
https://doi.org/10.1016/j.jsxm.2016.11.324
The Journal of Sexual Medicine; Salonia A, Adaikan G et. al.

Mar 7th, 2017 - Sexual dysfunction is common in patients after radical prostatectomy (RP) for prostate cancer. To provide the International Consultation for Sexual Medicine (ICSM) 2015 recommendations concerning management strategies for post-RP erectile function...

see more →

Clinicaltrials.gov  231 results

Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT03860987

May 13th, 2022 - Background: Most men diagnosed with prostate cancer will present with intermediate or high-risk disease, and many develop castrate resistant prostate cancer (CRPC) as curative strategies are often unsuccessful Treatment options typically involve r...

Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
https://clinicaltrials.gov/ct2/show/NCT02319837

May 13th, 2022 - The purpose of this study is to assess enzalutamide plus leuprolide in patients with high-risk nonmetastatic prostate cancer progressing after radical prostatectomy or radiotherapy or both.

Combination Immunotherapy in Biochemically Recurrent Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT03315871

May 13th, 2022 - Background: Androgen deprivation therapy (ADT) and surveillance are treatment options for prostate cancer patients with biochemical progression after localized therapy (i.e., biochemically recurrent [BCR] prostate cancer). The primary goal in thes...

Early Prostate Cancer Recurrence With PSMA PET Positive Unilateral Pelvic Lesion(s)
https://clinicaltrials.gov/ct2/show/NCT04271579

May 9th, 2022 - In this prospective randomized study, patients with early biochemical recurrence after radical prostatectomy and with PSMA-PET positive unilateral pelvic metastatic lesions are assessed as to whether unilateral and bilateral salvage lymph node dis...

Adjuvant Apalutamide in Subjects With High-risk Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy
https://clinicaltrials.gov/ct2/show/NCT04295447

May 6th, 2022 - The primary objective of this trial is to determine if adjuvant apalutamide in prostate cancer patients at high risk of developing subsequent metastatic disease results in prolonged biochemically recurrence-free survival after radical prostatectom...

see more →

News  489 results

18F-rhPSMA-7.3 Imaging Favorable Detection Rates in Men with Recurrent Prostate Cancer
https://www.onclive.com/view/18f-rhpsma-7-3-imaging-favorable-detection-rates-in-men-with-recurrent-prostate-cancer

Feb 18th, 2022 - The utilization of 18F-rhPSMA-7.3 imaging displayed a clinically meaningful correct detection rate (CDR), meeting the prespecified threshhold of assessing suspected biochemical recurrence in prostate cancer, according to findings from the phase 3 ...

Prostate cancer: Salvage radiotherapy after surgery extends long-term survival
https://www.mdedge.com/fedprac/article/251833/prostate-cancer/prostate-cancer-salvage-radiotherapy-after-surgery-extends

Feb 15th, 2022 - Key clinical point: In patients with prostate cancer, salvage radiotherapy (SRT) for biochemical recurrence after radical prostatectomy is associated with improved survival in the long term. Major finding: The median follow up was 95.

Can Prostate Cancer Patients on AS Delay Surgery at Progression?
https://www.medpagetoday.com/urology/prostatecancer/96685

Jan 14th, 2022 - Among men with clinically localized prostate cancer who continued active surveillance (AS) after biopsy progression, delaying surgery did not significantly reduce recurrence-free survival (RFS) rates or increase the risk of adverse pathology, rese...

Prostatectomy Without Biopsy Is Feasible, Says German Study
https://www.medscape.com/viewarticle/965729

Dec 29th, 2021 - Radical prostatectomy after confirmation of cancer via two advanced imaging techniques without biopsy is feasible, according to a retrospective study of 25 patients who refused biopsies. "Results of our case series may trigger the discussion about...

Prostate cancer: Severe urinary incontinence after surgery is common
https://www.mdedge.com/fedprac/article/250061/prostate-cancer/prostate-cancer-severe-urinary-incontinence-after-surgery

Dec 18th, 2021 - Key clinical point: More than 9% of men with prostate cancer undergoing radical prostatectomy report a bad urinary incontinence score. Only approximately 9% of these men receive subsequent incontinence surgery.

see more →

Patient Education  4 results see all →